Currently Viewing:
Newsroom

New Opportunities and Challenges in Hepatitis C

Hepatitis C is an enormously common disease that is often initially asymptomatic. New drugs are very effective, but expensive, and there has been reluctance to cover these treatments. Authors that published research in the hepatitis C special issue present their findings.



Jay Bhattacharya, MD, PhD, opens up the hepatitis C virus (HCV) briefing, which highlighted research published in The American Journal of Managed Care's special issue on HCV. He provided a brief overview of the scope of HCV infection in the US and around the world, as well as the reluctance on the part of payers to cover the expensive drugs, even though they essentially cure the disease.

Bhattacharya served as the guest editor of the special issue, gave short summaries of some of the papers that would be presented at the briefing, and introduced the speakers.


 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!